UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries. Published On 5 Sep 20255 Sep 2025 The World Health Organization (WHO) has added a new set of drugs for obesity and diabetes to its essential medicines list, alongside treatments for cancer and cystic fibrosis. Cheap generic versions of the glucagon-like peptide-1 …
Read More »
Today, the World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity. Medicines for cystic fibrosis, psoriasis, haemophilia and blood-related disorders are among the other additions. WHO EML and EMLc include medicines …
Read More »
Although pharmaceuticals usually go through decades of development and testing to ensure they are safe and effective, there are thousands of types of drugs on the market and millions of combinations of foods they could be paired with. Scientific reviews suggest food interactions can be a major threat to safe and effective oral pharmacotherapy. Experts are only now starting to …
Read More »LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is “highly effective” and “considered to be of …
Read More »